Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | ACT-385781A (Actelion Epoprostenol) | [1] Epoprostenol Epoprostenol (Epoprostenol for Injection) | [1] Epoprostenol
Epoprostenol
(Epoprostenol, Epoprostenol) 💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 2 | Combination injection of EPO and G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 6 6 💬
|
| 3 | Current marketed FLOLAN (epoprostenol sodium) | [1] Epoprostenol Epoprostenol (Epoprostenol for Injection) | [1] Epoprostenol
Epoprostenol
(Epoprostenol, Epoprostenol) 💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 4 | EPO | - | - | - | - | [1] 13 13 💬
|
| 5 | Epoeitin beta | - | - | - | - | [1] 18 18 💬
|
| 6 | Epoetin alfa | [1] Erythropoietin Erythropoietin (Epoetin kappa) | - | - | - | [3] 13 13, 18, 46 💬
|
| 7 | Epoetin beta | [1] Erythropoietin Erythropoietin (Epoetin kappa) | - | - | - | [1] 13 13 💬
|
| 8 | EPOPROSTENOL | [1] Epoprostenol Epoprostenol (Epoprostenol for Injection) | [1] Epoprostenol
Epoprostenol
(Epoprostenol, Epoprostenol) 💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 9 | Epoprostenol for injection | [1] Epoprostenol Epoprostenol (Epoprostenol for Injection) | [1] Epoprostenol
Epoprostenol
(Epoprostenol, Epoprostenol) 💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 10 | EPOPROSTENOL SODICO | [1] Epoprostenol Epoprostenol (Epoprostenol for Injection) | [1] Epoprostenol
Epoprostenol
(Epoprostenol, Epoprostenol) 💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 11 | EPOPROSTENOL SODIUM | [1] Epoprostenol Epoprostenol (Epoprostenol for Injection) | [1] Epoprostenol
Epoprostenol
(Epoprostenol, Epoprostenol) 💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 12 | Epoprostenol-Actelion | [1] Epoprostenol Epoprostenol (Epoprostenol for Injection) | [1] Epoprostenol
Epoprostenol
(Epoprostenol, Epoprostenol) 💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 13 | Epoprostenolo per iniezione | - | - | - | - | [1] 86 86 💬
|
| 14 | Erythropoetin (EPO) | - | - | - | - | [1] 2 2 💬
|
| 15 | Erythropoietin human recombinant (EPOrh) | [1] Erythropoietin Erythropoietin (Epoetin kappa) | - | - | - | [1] 6 6 💬
|
| 16 | New thermo stable formulation of epoprostenol sodium | [1] Epoprostenol Epoprostenol (Epoprostenol for Injection) | [1] Epoprostenol
Epoprostenol
(Epoprostenol, Epoprostenol) 💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|